Moor CC - Search Results

1

Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis.

Moor CC, Gür-Demirel Y, Wijsenbeek MS. Moor CC, et al. J Pers Med. 2019 May 5;9(2):23. doi: 10.3390/jpm9020023. J Pers Med. 2019. PMID: 31060343 Free PMC article.

2

Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation.

Kreuter M, Polke M, Walsh SLF, Krisam J, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte T, Flaherty K, Funke-Chambour M, Kolb M, Kondoh Y, Maher TM, Molina Molina M, Morais A, Moor CC, Morisset J, Pereira C, Quadrelli S, Selman M, Tzouvelekis A, Valenzuela C, Vancheri C, Vicens-Zygmunt V, Wälscher J, Wuyts W, Wijsenbeek M, Cottin V, Bendstrup E. Kreuter M, et al. Among authors: moor cc. Eur Respir J. 2020 Apr 3;55(4):1901760. doi: 10.1183/13993003.01760-2019. Print 2020 Apr. Eur Respir J. 2020. PMID: 32060068 Free article.

3

Clubbing in patients with fibrotic interstitial lung diseases.

van Manen MJG, Vermeer LC, Moor CC, Vrijenhoeff R, Grutters JC, Veltkamp M, Wijsenbeek MS. van Manen MJG, et al. Among authors: moor cc. Respir Med. 2017 Nov;132:226-231. doi: 10.1016/j.rmed.2017.10.021. Epub 2017 Nov 2. Respir Med. 2017. PMID: 29229102 Free article.

4

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis.

Moor CC, Heukels P, Kool M, Wijsenbeek MS. Moor CC, et al. Front Med (Lausanne). 2017 Dec 20;4:226. doi: 10.3389/fmed.2017.00226. eCollection 2017. Front Med (Lausanne). 2017. PMID: 29326935 Free PMC article. Review.

5

Development and feasibility of an eHealth tool for idiopathic pulmonary fibrosis.

Moor CC, van Manen MJG, Tak NC, van Noort E, Wijsenbeek MS. Moor CC, et al. Eur Respir J. 2018 Mar 29;51(3):1702508. doi: 10.1183/13993003.02508-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29348156 Free article. No abstract available.

6

A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.

Moor CC, Wapenaar M, Miedema JR, Geelhoed JJM, Chandoesing PP, Wijsenbeek MS. Moor CC, et al. Respir Res. 2018 May 29;19(1):105. doi: 10.1186/s12931-018-0810-3. Respir Res. 2018. PMID: 29843728 Free PMC article.

7

Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners.

Moor CC, van Manen MJG, van Hagen PM, Miedema JR, van den Toorn LM, Gür-Demirel Y, Berendse APC, van Laar JAM, Wijsenbeek MS. Moor CC, et al. Lung. 2018 Oct;196(5):569-575. doi: 10.1007/s00408-018-0144-4. Epub 2018 Aug 7. Lung. 2018. PMID: 30088094 Free PMC article.

8

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study.

Wijsenbeek M, Bendstrup E, Valenzuela C, Henry MT, Moor C, Bengus M, Perjesi A, Gilberg F, Kirchgaessler KU, Vancheri C. Wijsenbeek M, et al. Adv Ther. 2019 Jan;36(1):232-243. doi: 10.1007/s12325-018-0845-3. Epub 2018 Nov 30. Adv Ther. 2019. PMID: 30506309 Free PMC article.

9

Comprehensive Care for Patients with Sarcoidosis.

Moor CC, Kahlmann V, Culver DA, Wijsenbeek MS. Moor CC, et al. J Clin Med. 2020 Feb 1;9(2):390. doi: 10.3390/jcm9020390. J Clin Med. 2020. PMID: 32024123 Free PMC article. Review.

10

Diurnal variation in forced vital capacity in patients with fibrotic interstitial lung disease using home spirometry.

Moor CC, van den Berg CAL, Visser LS, Aerts JGJV, Cottin V, Wijsenbeek MS. Moor CC, et al. ERJ Open Res. 2020 Apr 6;6(1):00054-2020. doi: 10.1183/23120541.00054-2020. eCollection 2020 Jan. ERJ Open Res. 2020. PMID: 32280666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results